QUILLIVANT XR

Live / Registered — Registered and renewed (as of 08 Jul 2024)

What this means for you

Registered since 08 Apr 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Apr 2024).

Record

Serial number
85704149
Registration number
4511557
Mark type
Stylized text
Filed
15 Aug 2012
Published for opposition
18 Jun 2013
Registered
08 Apr 2014
Next maintenance due
08 Apr 2024
Attorney of record
Cathy A. Kodroff

Goods and services

  • Class 005 — Pharmaceuticals: Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder

Owner

Prosecution history

  • 08 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 08 Jul 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 08 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 05 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 08 Apr 2024 — TEAS SECTION 8 & 9 RECEIVED
  • 08 Apr 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 26 Aug 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 26 Aug 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 26 Aug 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 16 Jul 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 16 Jul 2019 — TEAS SECTION 8 & 15 RECEIVED
  • 08 Apr 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 05 Feb 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 05 Feb 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 03 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

View this trademark record on Marksy